Document:

exv4w1

 

Exhibit 4.1

VOTING AGREEMENT

     This
Voting Agreement (the “Agreement”) is made and entered into as of July 2, 2007 by and
between Transmeta Company, a Delaware corporation (the “Company”), and Advanced Micro Devices, Inc.
a Delaware corporation (together with its permitted successors, assigns and transferees, “AMD”).

RECITALS

     WHEREAS, concurrently with the execution of this Agreement, the Company and AMD are entering
into a Stock Purchase Agreement (as amended from time to time, the “Purchase Agreement”) that
provides for the sale to AMD of shares of the Company’s Series B Preferred Stock, par value
$0.00001 per share (the “Series B Preferred Stock”), which shares of Series B Preferred Stock are
convertible into shares of the Company’s Common Stock (the “Common Stock”); such shares of Series B
Preferred Stock, together with any shares of Series B Preferred Stock issued or issuable with
respect to or in exchange for the shares of Series B Preferred Stock sold under the Purchase
Agreement, are collectively referred to herein as the “Shares.”

     WHEREAS, in connection with AMD’s acquisition of the Shares, the Company and AMD
desire to set forth their agreements and understandings with respect to the voting of the Shares in
the event the Company becomes subject to Section 2115 of the California General Corporations Law
(the “CGCL”).

AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing recitals and the covenants and agreements
set forth herein, together with other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereby agree as follows:

     1. Bring-Along Right.

               1.1 Actions to be Taken. If (A) (i) the holders of a majority of the then-outstanding
shares of Common Stock (the “Majority Holders”) approve (1) the merger or consolidation of the
Company by means of any transaction or series of related transactions, provided that the
Company’s stockholders constituted immediately prior to such transaction hold less than 50% of the
voting power of the surviving or acquiring entity immediately after such transaction; or (2) a sale
of all or substantially all of the assets of the Corporation requiring approval of the Company’s
stockholders, that is followed by the distribution of the proceeds from that sale to the Company’s
stockholders (in each case, a “Liquidation”) and (ii) the Board of Directors of the Company (the
“Board”) approves such Liquidation and (B) at the time of the vote to approve the Liquidation, the
Company is subject to Section 2115 of the CGCL, as evidenced by a certificate of the Chief
Executive Officer or Chief Financial Officer of the Company certifying that the Company is subject
to Section 2115 of the CGCL (the “Officer’s
Certificate”), and the provisions of Section 1201 of the CGCL requires that the principal
terms of such Liquidation be approved by any class of outstanding preferred shares of the Company
in order to consummate such Liquidation, then AMD hereby agrees:

 

 

                         (a) to vote (in person or by proxy, as applicable) all Shares in favor of, and tender all
Shares in support of, such Liquidation; and

                         (b) to execute and deliver all related documentation and take such other action in support of
such Liquidation as shall reasonably be requested by the Company in order to carry out the terms
and provisions of this Section 1.

               1.2 Exceptions. Notwithstanding the foregoing, AMD will not be required to comply
with Section 1.1 above in connection with any Liquidation unless:

                         (a) neither the execution and delivery by AMD of documents to be entered into in connection
with such Liquidation, nor the performance of AMD’s obligations thereunder, will cause a breach or
violation of the terms of any law or judgment, order or decree of any court or governmental agency;
or

                         (b) upon the consummation of such Liquidation, the consideration receivable by AMD with
respect to the Shares is in accordance with the provisions of the Certificate of Designation.

               1.3 Officer’s Certificate. The Officer’s Certificate described in Section 1.1
above shall be delivered to AMD by the Company at least ten (10) business days prior to the date on
which the Company solicits AMD’s vote pursuant to this Agreement and shall be accompanied by
documentation supporting the Company’s determination that the Company is subject to Section 2115 of
the CGCL. If AMD disagrees with the Company’s determination, AMD shall notify the Company within
five (5) business days of receipt of the Officer’s Certificate and supporting documentation from
the Company. For the next five (5) business days thereafter, the Company and AMD each agree to
negotiate in good faith to resolve the dispute. If AMD does not notify the Company that it
disagrees with the Company’s determination, at the end of ten (10) business days following receipt
of the Officer’s Certificate, AMD shall have been deemed to agree with the Company’s determination
and the Company shall be entitled to enforce the terms of this Agreement against AMD.

     2. Remedies.

               2.1 Specific Enforcement. AMD acknowledges and agrees that the Company will be
irreparably harmed in the event any of the provisions of this Agreement are not performed by AMD in
accordance with their specific terms or are otherwise breached. Accordingly, it is agreed that the
Company shall be entitled to an injunction to prevent breaches of this Agreement, and to specific
enforcement of this Agreement and its terms and provisions in any action instituted in any court of
the United States or any state having subject matter jurisdiction.

               2.2 Remedies Cumulative. All remedies, either under this Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.

     3. Term. This Agreement shall be effective as of the date hereof and shall continue
in effect until and shall terminate upon the earliest to occur of (a) the consummation of a
Liquidation, provided that the provisions of Section 1 hereof will continue after the
closing of

2

 

any Liquidation to the extent necessary to enforce the provisions of Section 1
with respect to such Liquidation; (b) termination of this Agreement in accordance with Section
4.7 below; or (c) the date on which no Shares remain outstanding.

     4. Miscellaneous.

               4.1 Transfers. Each transferee or assignee of any Shares subject to this Agreement
shall continue to be subject to the terms hereof, and, as a condition precedent to the Company’s
recognizing such transfer, AMD (or any of its permitted transferees or assigns) agrees to cause
each transferee or assignee to agree in writing to be subject to each of the terms of this
Agreement by executing and delivering a writing in form and substance satisfactory to the Company
stating that such transferee agrees to be bound by all provisions hereof. Upon the execution and
delivery of such a writing, such transferee shall be deemed to be a party hereto as if such
transferee were the transferor and such transferee’s signature appeared on the signature pages of
this Agreement and shall be deemed to be “AMD” for all purposes of this Agreement. The Company
shall not permit the transfer of the Shares subject to this Agreement on its books or issue a new
certificate representing any such Shares unless and until such transferee shall have complied with
the terms of this Section 4.1. Each certificate representing the Shares subject to this
Agreement if issued on or after the date of this Agreement shall be endorsed by the Company with
the legend set forth in Section 4.11.

               4.2 Successors and Assigns. The terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the respective successors and assigns of the parties. Nothing
in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement.

               4.3 Governing Law. This Agreement and any controversy arising out of or relating to
this Agreement shall be governed by and construed in accordance with the General Corporation Law of
the State of Delaware as to matters within the scope thereof, and as to all other matters shall be
governed by and construed in accordance with the internal laws of the State of California, without
regard to conflict of law principles that would result in the application of any law other than the
law of the State of California.

               4.4 Counterparts; Facsimile. This Agreement may be executed and delivered by
facsimile signature and in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.

               4.5 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

               4.6 Notice. Any notice or other communication required or permitted hereunder must be
in writing, and shall be delivered personally, by facsimile or by certified,
registered, or express mail, postage prepaid and return receipt requested. Such notice shall
be deemed given when so delivered personally or when sent by confirmed facsimile transmission

3

 

on a business day to the party in question or, if mailed, three (3) business days after the date of
deposit in the United States mails, as follows:

          (a) if to the Company:

Transmeta Corporation

3990 Freedom Circle

Santa Clara, CA 95054

Attn: President

Fax: (408) 919-6540

with a copy to:

Transmeta Corporation

3990 Freedom Circle

Santa Clara, CA 95054

Attn: General Counsel

Fax: (408) 919-5286

and

Mark A. Leahy, Esq.

Fenwick & West LLP

801 California Street

Mountain View, CA 94041

Fax: (650) 938-5200

          (b) if to AMD, to:

Advanced Micro Devices, Inc.

5204 East Ben White Blvd

Austin, TX 78741

Attn: Harry Wolin, Senior Vice President and General Counsel

Fax: (512) 602-4932

with a copy to:

Faina Medzonsky

Advanced Micro Devices, Inc.

One AMD Place, m/s 68

P.O. Box 3453

Sunnyvale, CA 94088-3453

Fax: (408) 774-7002

               4.7 Consent Required to Amend or Waive. This Agreement may be amended or modified and
the observance of any term hereof may be waived (either generally or in a
particular instance and either retroactively or prospectively) only by a written instrument
executed by holders of a majority of the then-outstanding Shares and the Company. The

4

 

Company
shall give prompt written notice of any amendment or waiver hereunder to any party that did not
consent in writing thereto. Any amendment or waiver effected in accordance with this Section
4.7 shall be binding on each party and all of such party’s successors and permitted assigns,
whether or not any such party, successor or assignee entered into or approved such amendment or
waiver.

               4.8 Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default previously
or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the
part of any party of any breach or default under this Agreement, or any waiver on the part of any
party of any provisions or conditions of this Agreement, must be in writing and shall be effective
only to the extent specifically set forth in such writing. All remedies, either under this
Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

               4.9 Severability. The invalidity or unenforceability of any provision hereof shall in
no way affect the validity or enforceability of any other provision.

               4.10 Entire Agreement. This Agreement, the Purchase Agreement, the Related Agreements
(as defined in the Purchase Agreement), the Company’s Second Amended and Restated Certificate of
Incorporation and the Certificate of Designation, constitute the full and entire understanding and
agreement between the parties with respect to the subject matter hereof, and any other written or
oral agreement relating to the subject matter hereof existing between the parties are expressly
canceled.

               4.11 Legend on Share Certificates. Each certificate representing any Shares issued on
or after the date hereof shall be endorsed by the Company with a legend reading substantially as
follows:

“THE SHARES EVIDENCED HEREBY ARE SUBJECT TO A VOTING AGREEMENT, AS MAY BE
AMENDED FROM TIME TO TIME, (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST
FROM THE ISSUER), AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING
SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE
PROVISIONS OF THAT VOTING AGREEMENT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER AND
OWNERSHIP SET FORTH THEREIN.”

The Company, by its execution of this Agreement, agrees that it will cause the certificates
evidencing the Shares and any securities issued upon conversion of or in exchange for the Shares
issued after the date hereof to bear the legend required by this Section 4.11 of this
Agreement, and it shall supply, free of charge, a copy of this Agreement to any holder of a
certificate
evidencing Shares upon written request from such holder to the Company at its principal office.
The parties to this Agreement do hereby agree that the failure to cause the certificates evidencing

5

 

the Shares to bear the legend required by this Section 4.11 herein and/or the failure of
the Company to supply, free of charge, a copy of this Agreement as provided hereunder shall not
affect the validity or enforcement of this Agreement.

               4.12 Further Assurances. At any time or from time to time after the date hereof, the
parties agree to cooperate with each other, and at the request of any other party, to execute and
deliver any further instruments or documents and to take all such further action as the other party
may reasonably request in order to evidence or effectuate the consummation of the transactions
contemplated hereby and to otherwise carry out the intent of the parties hereunder.

               4.13 Costs of Enforcement. If any party to this Agreement seeks to enforce its rights
under this Agreement by legal proceedings, the non-prevailing party shall pay all costs and
expenses incurred by the prevailing party, including, without limitation, all reasonable attorneys’
fees.

               4.14 Acknowledgment. The parties hereby acknowledge that this Agreement only governs
the voting of the Shares in the event the Company is subject to Section 2115 of the CGCL and
neither AMD nor any transferee or assignee hereunder will be bound by this Agreement with respect
to any shares of Common Stock issued upon conversion of the Shares or any other shares of capital
stock of the Company held by them.

[Signature Page Follows]

6

 

     IN WITNESS WHEREOF, the parties hereto have executed this Voting Agreement as of the date
first written above.

	 	 	 	 	 
	 	Transmeta Corporation,

a Delaware Corporation

 	 
	 	By:  	/s/ Lester M. Crudele
 	 
	 	Name:  	Lester M. Crudele 	 
	 	Its:	President and Chief Executive Officer
	 	Date: 	July 2, 2007 
	 
	 	Advanced Micro Devices, Inc.,

a Delaware corporation

 	 
	 	By:  	/s/ Derrick R. Meyer
 	 
	 	Name:  	Derrick R. Meyer 	 
	 	Its:	President and Chief Operating Officer
	 	Date: 	July 2, 2007exv4w2

 

Exhibit 4.2

REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement (the “Agreement”) is made and entered into as of the
2nd day of July, 2007 by and between Transmeta Corporation, a Delaware corporation (the
“Company”), and Advanced Micro Devices, Inc., a Delaware corporation, and shall be effective as of
the Closing (as such term is defined in the Purchase Agreement) of the transactions contemplated by
the Purchase Agreement.

     The parties hereby agree as follows:

     1. Certain Definitions.

     As used in this Agreement, the following terms shall have the following meanings:

     “Affiliate” means, with respect to any person, any other person which directly or
indirectly controls, is controlled by, or is under common control with, such person.

     “AMD” shall mean Advanced Micro Devices, Inc. and any Affiliate or permitted
transferee of AMD who is a subsequent holder of any Registrable Securities.

     “Business Day” means a day, other than a Saturday or Sunday, on which banks in New
York City are open for the general transaction of business.

     “Common Stock” shall mean the Company’s common stock, par value $0.00001 per share,
and any securities into which such shares may hereinafter be reclassified.

     “Prospectus” shall mean the prospectus included in any Registration Statement, as
amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by such Registration Statement and by all other
amendments and supplements to the prospectus, including post-effective amendments and all material
incorporated by reference in such prospectus.

     “Purchase Agreement” shall mean the Stock Purchase Agreement, dated as of July 3,
2007, by and between the Company and AMD.

     “Register,” “registered” and “registration” refer to a registration
made by preparing and filing a Registration Statement or similar document in compliance with the
1933 Act (as defined below), and the declaration or ordering of effectiveness of such Registration
Statement or document.

     “Registrable Securities” shall mean (i) the Common Stock issuable or issued upon
conversion of the Shares and (ii) any Common Stock issued or issuable with respect to or in
exchange for Registrable Securities, excluding any Registrable Securities sold by a person in a
transaction in which his, her or its rights under this Agreement are not assigned to the purchaser;
provided, that, a security shall cease to be a Registrable Security upon (A) sale pursuant to a
Registration Statement or Rule 144 under the 1933 Act, or (B) such security becoming eligible for
sale by AMD pursuant to Rule 144(k).

     “Registration Statement” shall mean any registration statement of the Company filed
under the 1933 Act that covers the resale of any of the Registrable Securities pursuant to the
provisions of this Agreement, amendments and supplements to such Registration Statement,
including post-effective amendments, all exhibits and all material incorporated by reference
in such Registration Statement.

 

 

     “Rule 144” means Rule 144 as promulgated by the SEC under the 1933 Act, as such Rule
may be amended from time to time, or any similar successor rule that may be promulgated by the SEC.

     “Rule 145” means Rule 145 as promulgated by the SEC under the 1933 Act, as such Rule
may be amended from time to time, or any similar successor rule that may be promulgated by the SEC.

     “SEC” means the U.S. Securities and Exchange Commission or any other federal agency at
the time administering the 1933 Act.

     “Shares” means the shares of Series B Preferred Stock issued pursuant to the Purchase
Agreement.

     “1933 Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.

     “1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.

     2. Registrations.

          (a) Demand Registration. If, at any time following July 3, 2008, the Company shall
receive from AMD a written request to register the Registrable Securities, the Company shall
prepare and file with the SEC one Registration Statement on Form S-3 (or, if Form S-3 is not then
available to the Company, on such form of registration statement as is then available to effect a
registration for resale of the Registrable Securities), covering the resale of the Registrable
Securities. The Registration Statement (and each amendment or supplement thereto, and each request
for acceleration of effectiveness thereof) shall be provided in accordance with Section 3(c) to AMD
and its counsel prior to its filing or other submission.

          (b) Piggyback Registration. If the Company shall determine to register any of its
securities for its own account other than (A) a registration relating solely to employee benefit
plans, (B) a registration relating solely to a Rule 145 transaction or (C) a registration on any
registration form that does not permit secondary sales, the Company will: (i) promptly deliver to
AMD written notice thereof and (ii) use its commercially reasonable efforts to include in such
registration (and any related qualification under blue sky laws or other compliance) and in any
underwriting involved therein, all the Registrable Securities specified in a written request made
by AMD and delivered to the Company within ten (10) days after the written notice is delivered by
the Company. Such written request may include all or a portion of the Registrable Securities. The
Registration Statement (and each amendment or supplement thereto, and each request for acceleration
of effectiveness thereof) shall be provided in accordance with Section 3(c) to AMD and its counsel
prior to its filing or other submission. If the registration of which the Company gives notice is
for a registered offering involving an underwriting, the Company shall so advise AMD as a part of
the written notice given pursuant to this Section 2(b). In such event, the right of AMD to
registration pursuant to this Section 2(b) shall be conditioned upon AMD’s participation in such
underwriting and the inclusion of AMD’s Registrable Securities in the underwriting to the extent
provided herein. If AMD
participates in such underwriting, AMD shall enter into an underwriting agreement in customary
form with the underwriter or underwriters selected for such underwriting by the Company.

2

 

Notwithstanding any other provision of this Section 2(b), if, in an underwritten offering, the
Company, upon advice of the underwriter, advises AMD in writing that marketing factors require a
limitation of the number of shares to be underwritten, then the number of shares of Registrable
Securities that may be included in the underwriting may be reduced by the Company to an amount
that, together with the number of shares that the Company shall determine to register in that
registration and underwriting for the account of one or more other security holder or holders,
shall not be less than forty percent (40%) of the securities included in such registration and
underwriting, with the number of shares of Registrable Securities and shares held by other security
holders included in that registration and underwriting to be allocated among the holders thereof on
a pro rata basis according to the number of shares requested by each such holder to be included in
that registration and underwriting.

               (c) Expenses. The Company will pay all expenses associated with each registration,
including filing and printing fees, the Company’s counsel and accounting fees and expenses, costs
associated with clearing the Registrable Securities for sale under applicable state securities
laws, listing fees, fees and reasonable expenses of one counsel to AMD, but excluding discounts,
commissions, fees of underwriters, selling brokers, dealer managers or similar securities industry
professionals with respect to the Registrable Securities being sold.

               (d) Effectiveness.

               (i) The Company shall use commercially reasonable efforts to have the Registration Statement
declared effective as soon as practicable. The Company shall notify AMD by facsimile or e-mail as
promptly as practicable, and in any event, within twenty-four (24) hours, after any Registration
Statement is declared effective and shall simultaneously provide AMD with copies of any related
Prospectus to be used in connection with the sale or other disposition of the securities covered
thereby.

               (ii) For not more than twenty (20) consecutive days or for a total of not more than forty-five
(45) days in any twelve (12) month period, the Company may delay the disclosure of material
non-public information concerning the Company by suspending the use of any Prospectus included in
any registration contemplated by this Section 2 containing such information, the disclosure of
which at the time is not, in the good faith opinion of the Company, in the best interests of the
Company (an “Allowed Delay”); provided, that the Company shall promptly (a) notify AMD in writing
of the existence of (but in no event, without the prior written consent of AMD, shall the Company
disclose to AMD any of the facts or circumstances regarding) material non-public information giving
rise to an Allowed Delay, (b) advise AMD in writing to cease all sales under the Registration
Statement until the end of the Allowed Delay and (c) use commercially reasonable efforts to
terminate an Allowed Delay as promptly as practicable.

     3. Company Obligations. The Company will use commercially reasonable efforts to
effect the registration of the Registrable Securities in accordance with the terms hereof, and
pursuant thereto the Company will, as expeditiously as possible:

               (a) use commercially reasonable efforts to cause such Registration Statement to become
effective and to remain continuously effective for a period that will

3

 

terminate upon the earlier of
(i) the date on which all Registrable Securities covered by such Registration Statement as amended
from time to time have been sold and (ii) the date on which all Registrable Securities covered by
such Registration Statement may be sold pursuant to Rule 144(k) (the “Effectiveness Period”) and
advise AMD in writing when the Effectiveness Period has expired;

               (b) prepare and file with the SEC such amendments and post-effective amendments to the
Registration Statement and the Prospectus as may be necessary to keep the Registration Statement
effective for the period specified in Section 3(a) and to comply with the provisions of the 1933
Act and the 1934 Act with respect to the distribution of all of the Registrable Securities covered
thereby;

               (c) provide copies to and permit counsel designated by AMD to review the Registration
Statement and all amendments and supplements thereto no fewer than five (5) Business Days prior to
their filing with the SEC and duly consider comments made by such counsel thereon;

               (d) furnish to AMD and its legal counsel (i) promptly after the same is prepared and publicly
distributed, filed with the SEC, or received by the Company (but not later than two (2) Business
Days after the filing date, receipt date or sending date, as the case may be) one (1) copy of any
Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and
each amendment or supplement thereto, and each letter written by or on behalf of the Company to the
SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC,
in each case relating to such Registration Statement (other than any portion of any thereof which
contains information for which the Company has sought confidential treatment), and (ii) an
electronic copy of a Prospectus, including a preliminary prospectus, and all amendments and
supplements thereto and such other documents as AMD may reasonably request in connection with the
disposition of the Registrable Securities owned by AMD that are covered by the related Registration
Statement;

               (e) use commercially reasonable efforts to (i) prevent the issuance of any stop order or other
suspension of effectiveness and, (ii) if such order is issued, obtain the withdrawal of any such
order at the earliest possible moment;

               (f) prior to any public offering of Registrable Securities, use commercially reasonable
efforts to register or qualify or cooperate with AMD and its counsel in connection with the
registration or qualification of such Registrable Securities for offer and sale under the
securities or blue sky laws of such jurisdictions requested by AMD and do any and all other
commercially reasonable acts or things necessary or advisable to enable the distribution in such
jurisdictions of the Registrable Securities covered by the Registration Statement; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto
to (i) qualify to do business in any jurisdiction where it would not otherwise be required to
qualify but for this Section 3(f), (ii) subject itself to general taxation in any jurisdiction
where it would not otherwise be so subject but for this Section 3(f), or (iii) file a general
consent to service of process in any such jurisdiction;

4

 

               (g) use commercially reasonable efforts to cause all Registrable Securities covered by a
Registration Statement to be listed on each securities exchange, interdealer quotation system or
other market on which similar securities issued by the Company are then listed;

               (h) immediately notify AMD, at any time when a Prospectus relating to Registrable Securities
is required to be delivered under the 1933 Act, upon discovery that, or upon the happening of any
event as a result of which, the Prospectus included in a Registration Statement, as then in effect,
includes an untrue statement of a material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein not misleading in light of the
circumstances then existing, and at the request of AMD, promptly prepare and furnish to AMD an
electronic copy of a supplement to or an amendment of such Prospectus as may be necessary so that,
as thereafter delivered to the purchasers of such Registrable Securities, such Prospectus shall not
include an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading in light of the
circumstances then existing; and

               (i) otherwise use commercially reasonable efforts to comply with all applicable rules and
regulations of the SEC under the 1933 Act and the 1934 Act, take such other actions as may be
reasonably necessary to facilitate the registration of the Registrable Securities hereunder and
make available to its security holders, as soon as reasonably practicable, but not later than the
Availability Date (as defined below), an earnings statement covering a period of at least twelve
(12) months, beginning after the effective date of each Registration Statement, which earnings
statement shall satisfy the provisions of Section 11(a) of the 1933 Act, including Rule 158
promulgated thereunder (for the purpose of this subsection 3(i), “Availability Date” means the 45th
day following the end of the fourth fiscal quarter that includes the effective date of such
Registration Statement, except that, if such fourth fiscal quarter is the last quarter of the
Company’s fiscal year, “Availability Date” means the 90th day after the end of such fourth fiscal
quarter).

               (j) With a view to making available to AMD the benefits of Rule 144 and any other rule or
regulation of the SEC that may at any time permit AMD to sell shares of Common Stock to the public
without registration, the Company covenants and agrees to: (i) make and keep public information
available, as those terms are understood and defined in Rule 144, until the earlier of (A) the date
all of the Registrable Securities may be resold pursuant to Rule 144(k) or any other rule of
similar effect or (B) such date as all of the Registrable Securities shall have been resold; (ii)
file with the SEC in a timely manner all reports and other documents required of the Company under
the 1934 Act; and (iii) furnish to AMD upon request, as long as AMD owns any Registrable
Securities, (A) a written statement by the Company that it has complied with the reporting
requirements of the 1934 Act, (B) a copy of the Company’s most recent Annual Report on Form 10-K or
Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested in
order to avail AMD of any rule or regulation of the SEC that permits the selling of any such
Registrable Securities without registration.

     4. Due Diligence Review; Information. In the event that AMD notifies the Company that
it is reasonably necessary for AMD to conduct a due diligence review of the Company for the purpose
of availing itself of any defense to liability provided under Section 11

5

 

or Section 12 of the 1933 Act, the Company shall make available, during normal business hours,
for inspection and review by AMD and its advisors, all financial and other records, all filings
made with the SEC and all other corporate documents and properties of the Company as may be
reasonably necessary for the purpose of such review, and cause the Company’s officers, directors
and employees, within a reasonable time period, to supply all such information reasonably requested
by AMD or any such advisor in connection with such Registration Statement (including, without
limitation, in response to all questions and other inquiries reasonably made or submitted by any of
them), prior to and from time to time after the filing and effectiveness of the Registration
Statement for the sole purpose of enabling AMD and such advisors to conduct initial and ongoing due
diligence with respect to the Company and the accuracy of such Registration Statement.

               The Company shall not disclose material nonpublic information to AMD or its advisors pursuant
to this Section 4 unless prior to disclosure of such information the Company identifies such
information as being material nonpublic information and provides AMD or its advisors with the
opportunity to accept or refuse to accept such material nonpublic information for review and, if
AMD wishes to obtain such information, AMD enters into an appropriate confidentiality agreement
with the Company with respect thereto.

     5. Obligations of AMD.

               (a) AMD shall furnish in writing to the Company such information regarding itself, the
Registrable Securities held by it and the intended method of disposition of the Registrable
Securities held by it, as shall be reasonably required to effect the registration of such
Registrable Securities and shall execute such documents in connection with such registration as the
Company may reasonably request. At least five (5) Business Days prior to the first anticipated
filing date of any Registration Statement, the Company shall notify AMD of the information the
Company requires from AMD for AMD to have the Registrable Securities included in the Registration
Statement. AMD shall provide such information to the Company at least two (2) Business Days prior
to the first anticipated filing date of such Registration Statement.

               (b) AMD agrees to cooperate with the Company as reasonably requested by the Company in
connection with the preparation and filing of a Registration Statement hereunder.

               (c) AMD agrees that, upon receipt of any notice from the Company of either (i) the
commencement of an Allowed Delay pursuant to Section 2(d)(ii) or (ii) the happening of an event
pursuant to Section 3(h) hereof, AMD will immediately discontinue disposition of Registrable
Securities pursuant to the Registration Statement covering such Registrable Securities, until AMD’s
receipt of the supplemented or amended prospectus filed with the SEC and until any related
post-effective amendment is declared effective, if applicable, or until the termination of an
Allowed Delay, and, if so directed by the Company, AMD shall deliver to the Company (at the expense
of the Company) or destroy (and deliver to the Company a certificate of destruction) all copies in
AMD’s possession of the Prospectus covering the Registrable Securities current at the time of
receipt of such notice.

6

 

     6. Indemnification.

               (a) Indemnification by the Company. The Company will indemnify and hold harmless AMD
and its officers, directors, members, employees and agents, successors and assigns, and each other
person, if any, who controls AMD within the meaning of the 1933 Act, against any losses, claims,
damages or liabilities, joint or several, to which they may become subject under the 1933 Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon: (i) any untrue statement or alleged untrue statement of any
material fact contained in any Registration Statement, any preliminary prospectus or final
prospectus contained therein, the Prospectus or any amendment or supplement thereof; (ii) any blue
sky application or other document executed by the Company specifically for that purpose or based
upon written information furnished by the Company filed in any state or other jurisdiction in order
to qualify any or all of the Registrable Securities under the securities laws thereof (any such
application, document or information herein called a “Blue Sky Application”); (iii) the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading; (iv) any violation by the Company or its agents of any
rule or regulation promulgated under the 1933 Act applicable to the Company or its agents and
relating to action or inaction required of the Company in connection with such registration; or (v)
any failure to register or qualify the Registrable Securities included in any such Registration in
any state where the Company or its agents has affirmatively undertaken or agreed in writing that
the Company will undertake such registration or qualification on AMD’s behalf and will reimburse
AMD, and each such officer, director or member and each such controlling person for any legal or
other expenses reasonably incurred by it as incurred in connection with investigating or defending
any such loss, claim, damage, liability or action; provided, however, that the
indemnity agreement contained in this subsection 6(a) shall not apply to amounts paid in settlement
of any such loss, claim, damage, liability or action if such settlement is effected without the
consent of the Company (which consent shall not be unreasonably withheld); provided
further, however, that the Company will not be liable in any such case if and to
the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue
statement or alleged untrue statement or omission or alleged omission so made in conformity with
information furnished by AMD or any such controlling person in writing specifically for use in such
Registration Statement or Prospectus.

               (b) Indemnification by AMD. AMD agrees, severally but not jointly, to indemnify and
hold harmless, to the fullest extent permitted by law, the Company, its directors, officers,
employees, stockholders and each person who controls the Company (within the meaning of the 1933
Act) against any losses, claims, damages, liabilities and expense (including reasonable attorney
fees) resulting from any untrue statement or alleged untrue statement of a material fact or any
omission or alleged omission of a material fact required to be stated in the Registration Statement
or Prospectus or preliminary prospectus or amendment or supplement thereto or necessary to make the
statements therein not misleading, to the extent, but only to the extent that such untrue statement
or omission is contained in any information furnished in writing by AMD to the Company specifically
for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto;
provided, however, that the indemnity agreement contained in this subsection 6(b)
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of AMD (which consent shall not be unreasonably
withheld). In no event

7

 

shall the liability of AMD be greater in amount than the dollar amount of the proceeds (net of
all expense paid by AMD in connection with any claim relating to this Section 6 and the amount of
any damages AMD has otherwise been required to pay by reason of such untrue statement, alleged
untrue statement, omission or alleged omission) received by AMD upon the sale of the Registrable
Securities included in the Registration Statement giving rise to such indemnification obligation.

     (c) Conduct of Indemnification Proceedings. Any person entitled to indemnification
hereunder shall (i) give prompt notice to the indemnifying party of any claim with respect to which
it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such
claim with counsel reasonably satisfactory to the indemnified party; provided that any
person entitled to indemnification hereunder shall have the right to employ separate counsel and to
participate in the defense of such claim, but the fees and expenses of such counsel shall be at the
expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses,
or (b) the indemnifying party shall have failed to assume the defense of such claim within five (5)
Business Days after written notice thereof and employ counsel reasonably satisfactory to such
person or (c) in the reasonable judgment of any such person, based upon written advice of its
counsel, a conflict of interest exists between such person and the indemnifying party with respect
to such claims (in which case, if the person notifies the indemnifying party in writing that such
person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of such claim on behalf of such person); and
provided, further, that the failure of any indemnified party to give notice as
provided herein shall not relieve the indemnifying party of its obligations hereunder, except to
the extent that such failure to give notice shall materially adversely affect the indemnifying
party in the defense of any such claim or litigation. It is understood that the indemnifying party
shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or
expenses of more than one separate firm of attorneys at any time for all such indemnified parties.
No indemnifying party will, except with the consent of the indemnified party, consent to entry of
any judgment or enter into any settlement that does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such indemnified party of a release from all liability
in respect of such claim or litigation.

               (d) Contribution. If for any reason the indemnification provided for in the preceding
paragraphs (a) and (b) is unavailable to an indemnified party or insufficient to hold it harmless,
other than as expressly specified therein, then the indemnifying party shall contribute to the
amount paid or payable by the indemnified party as a result of such loss, claim, damage or
liability in such proportion as is appropriate to reflect the relative fault of the indemnified
party and the indemnifying party, as well as any other relevant equitable considerations. No
person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act
shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation.
In no event shall the contribution obligation of AMD be greater in amount than the dollar amount of
the proceeds (net of all expenses paid by such holder in connection with any claim relating to this
Section 6 and the amount of any damages such holder has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission) received by it upon the
sale of the Registrable Securities giving rise to such contribution obligation.

8

 

     7. Financial Information. The Company will furnish to AMD the following reports:

               (a) As soon as practicable after the end of each fiscal year, and in any event within ninety
(90) days thereafter, consolidated balance sheets of the Company and its subsidiaries, if any, as
of the end of such fiscal year, and consolidated statements of income and cash flows of the Company
and its subsidiaries, if any, for such year, prepared in accordance with generally accepted
accounting principles consistently applied, all in reasonable detail and certified by independent
public accountants of national standing selected by the Company. So long as the Company is
required to file reports under the 1934 Act and files in a timely manner such reports with the SEC,
the Company may provide written notice to AMD of the filing of its Annual Report on Form 10-K to
satisfy the foregoing delivery requirement.

               (b) As soon as practicable after the end of each of the first three quarters of each calendar
year, and in any event within forty-five (45) days thereafter, consolidated balance sheets of the
Company and its subsidiaries, if any, as of the end of each quarter, and consolidated statements of
income and cash flow for such period. With respect to the financial statements called for in this
Section 7(b), the Company shall deliver an instrument executed by the Chief Financial Officer or
President of the Company and certifying that such financial statements were prepared in accordance
with GAAP consistently applied with prior practice for earlier periods (with the exception of
footnotes that may be required by GAAP) and fairly present, in all material respects, the financial
condition of the Company and its results of operation for the period specified, subject to year-end
audit adjustment. So long as the Company is required to file reports under the 1934 Act and files
in a timely manner such reports with the SEC, the Company may provide written notice to AMD of the
filing of its Quarterly Report on Form 10-Q to satisfy the foregoing delivery requirement.

               (c) In the event the Company is no longer filing reports under the 1934 Act, as soon as
practicable, but in any event within fifteen (15) days prior to the end of each quarter of each
fiscal year of the Company, the monthly consolidated financial statements (balance sheet
(unaudited), income statement (unaudited) and statement of cash flows (unaudited)) for the first
two months of such quarter. The monthly consolidated financial statements of the last month of
each fiscal quarter shall be provided to AMD within fifteen (15) days following the end of such
fiscal quarter.

               (d) In the event the Company is no longer filing reports under the 1934 Act, AMD shall have
the right to receive such other information relating to the financial condition of the Company as
AMD or any assignee of AMD may from time to time reasonably request and discuss the Company’s
affairs, finances and accounts with its appropriate officers, all at such reasonable times as may
be requested by AMD; provided, however, that the Company shall not be obligated pursuant to this
Section 7(d) to provide access to any information which it reasonably considers to be a trade
secret or similar confidential information.

     8. Transfer of Registration Rights. The rights to cause the Company to register
securities granted by this Agreement may be transferred or assigned in writing by AMD to a
transferee or assignee, provided that such transfer or assignment is effected in accordance with
the terms of this Agreement and applicable securities laws; and provided further, that the Company
is given written notice of such transfer at the time of such transfer, stating the name

9

 

and address of the transferee or assignee and identifying the securities with respect to which
such registration rights are being transferred or assigned.

     9. Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of AMD, enter into any
agreement granting any holder or prospective holder of any securities of the Company registration
rights the terms of which would either materially and adversely impact the rights of AMD under this
Agreement or require the Company to violate the provisions of this Agreement.

     10. Miscellaneous.

               (a) Amendments and Waivers. This Agreement may be amended only by a writing signed by
the Company and AMD. The Company may take any action herein prohibited, or omit to perform any act
herein required to be performed by it, only if the Company shall have obtained the written consent
to such amendment, action or omission to act, of AMD.

               (b) Notices. All notices and other communications provided for or permitted hereunder
shall be made as set forth in the Purchase Agreement.

               (c) Assignment. The provisions of this Agreement shall be binding upon and inure to
the benefit of AMD and its successors and assigns.

               (d) Assignments and Transfers by the Company. This Agreement may not be assigned by
the Company (whether by operation of law or otherwise) without the prior written consent of AMD;
provided, however, that the Company may assign its rights and delegate its duties hereunder to any
surviving or successor corporation in connection with a merger or consolidation of the Company with
another corporation, or a sale, transfer or other disposition of all or substantially all of the
Company’s assets to another corporation, without the prior written consent of AMD, after notice
duly given by the Company to AMD.

               (e) Benefits of the Agreement. The terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective permitted successors and assigns of the
parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the parties hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement.

               (f) Counterparts; Faxes. This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument. This Agreement may also be executed via facsimile, which shall be deemed an
original.

               (g) Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

               (h) Severability. Any provision of this Agreement that is prohibited or unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of

10

 

such prohibition or unenforceability without invalidating the remaining provisions hereof but
shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted
by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction. To the extent
permitted by applicable law, the parties hereby waive any provision of law which renders any
provisions hereof prohibited or unenforceable in any respect.

               (i) Further Assurances. The parties shall execute and deliver all such further
instruments and documents and take all such other actions as may reasonably be required to carry
out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein
contained.

               (j) Entire Agreement. This Agreement is intended by the parties as a final expression
of their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein.

               (k) Termination. This Agreement shall terminate and be of no further force or effect
upon the consummation of a Liquidation (as such term is defined in the Certificate of Designations,
Preferences and Rights of Series B Preferred Stock of Transmeta Corporation) which results in
proceeds to the Company’s stockholders consisting solely of cash and/or publicly-traded securities.

               (l) Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement
shall be governed by, and construed in accordance with, the internal laws of the State of Delaware
without regard to the choice of law principles thereof. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the courts of the State of California located in Santa
Clara County and the United States District Court for the Northern District of California for the
purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement
and the transactions contemplated hereby. Service of process in connection with any such suit,
action or proceeding may be served on each party hereto anywhere in the world by the same methods
as are specified for the giving of notices under this Agreement. Each of the parties hereto
irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding
and to the laying of venue in such court. Each party hereto irrevocably waives any objection to
the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably
waives any claim that any such suit, action or proceeding brought in any such court has been
brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL
BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN
CONSULTED SPECIFICALLY AS TO THIS WAIVER.

11

 

     IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written.

	 	 	 	 	 
	 	Transmeta Corporation, 

a Delaware Corporation

 	 
	 	By:  	/s/ Lester M. Crudele 	 
	 	Name:  	Lester M. Crudele 	 
	 	Its:	 President and Chief Executive Officer
	 	Date: 	July 2, 2007  
	 
	 	Advanced Micro Devices, Inc.,

a Delaware corporation
 	 
	 	By:  	/s/ Derrick R. Meyer
 	 
	 	Name:  	Derrick R. Meyer 	 
	 	Its:	President and Chief Operating Officer
	 	Date: 	July 2, 2007 
	 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]